---
figid: PMC3142564__nihms212276f1
figtitle: Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Drosophila melanogaster
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC3142564
filename: nihms212276f1.jpg
figlink: /pmc/articles/PMC3142564/figure/F1/
number: F1
caption: Upon growth factor stimulation and subsequent activation of receptor tyrosine
  kinases (RTKs), class IA PI3Ks, consisting of p110α/p85, p110β/p85 and p110δ/p85,
  are recruited to the membrane via interaction of the p85 subunit to the activated
  receptors directly (e.g.PDGFR) or to adaptor proteins associated with the receptors
  (e.g. insulin receptor substrate 1, IRS1). The activated p110 catalytic subunit
  converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-triphosphate
  (PIP3) at the membrane, providing docking sites for signaling proteins with pleckstrin-homology
  (PH) domains including the phosphoinositide-dependent kinase 1 (PDK1) and the Ser-Thr
  kinase AKT. PDK1 phosphorylates and activates AKT (also known as PKB). The activated
  AKT elicits a broad spectrum of downstream signaling events. Class IB PI3K (p110γ/p101)
  can be activated directly by G-protein coupled receptors (GPCRs) through interacting
  with the Gβγ subunit of trimeric G proteins. The p110β and p110δ can also be activated
  by GPCRs. PTEN (phosphatase and tensin homologue) antagonizes the PI3K action by
  dephosphorylating PIP3. G βγ, guanine nucleotide binding protein (G protein), βγ;
  FKHR, forkhead transcription factor; NFκB, nuclear factor kappa-light-chain-enhancer
  of activated B cells; BAD, Bcl-2-associated death promoter protein; SGK, Serum and
  glucocorticoid-inducible kinase; PKC, protein kinase C; GSK3β, glycogen synthase
  kinase 3 beta; mTOR, mammalian target of rapamycin; Rac1, Ras-related C3 botulinum
  toxin substrate 1; S6K, ribosomal protein S6 kinase; LPA, lysophosphatidic acid.
papertitle: Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer.
reftext: Pixu Liu, et al. Nat Rev Drug Discov. ;8(8):627-644.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9699464
figid_alias: PMC3142564__F1
figtype: Figure
redirect_from: /figures/PMC3142564__F1
ndex: b1543c68-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3142564__nihms212276f1.html
  '@type': Dataset
  description: Upon growth factor stimulation and subsequent activation of receptor
    tyrosine kinases (RTKs), class IA PI3Ks, consisting of p110α/p85, p110β/p85 and
    p110δ/p85, are recruited to the membrane via interaction of the p85 subunit to
    the activated receptors directly (e.g.PDGFR) or to adaptor proteins associated
    with the receptors (e.g. insulin receptor substrate 1, IRS1). The activated p110
    catalytic subunit converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-triphosphate
    (PIP3) at the membrane, providing docking sites for signaling proteins with pleckstrin-homology
    (PH) domains including the phosphoinositide-dependent kinase 1 (PDK1) and the
    Ser-Thr kinase AKT. PDK1 phosphorylates and activates AKT (also known as PKB).
    The activated AKT elicits a broad spectrum of downstream signaling events. Class
    IB PI3K (p110γ/p101) can be activated directly by G-protein coupled receptors
    (GPCRs) through interacting with the Gβγ subunit of trimeric G proteins. The p110β
    and p110δ can also be activated by GPCRs. PTEN (phosphatase and tensin homologue)
    antagonizes the PI3K action by dephosphorylating PIP3. G βγ, guanine nucleotide
    binding protein (G protein), βγ; FKHR, forkhead transcription factor; NFκB, nuclear
    factor kappa-light-chain-enhancer of activated B cells; BAD, Bcl-2-associated
    death promoter protein; SGK, Serum and glucocorticoid-inducible kinase; PKC, protein
    kinase C; GSK3β, glycogen synthase kinase 3 beta; mTOR, mammalian target of rapamycin;
    Rac1, Ras-related C3 botulinum toxin substrate 1; S6K, ribosomal protein S6 kinase;
    LPA, lysophosphatidic acid.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pten
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Myb
  - Pi3K21B
  - Taf5
  - Pdk1
  - Akt
  - Pi3K59F
  - Pi3K68D
  - Mtor
  - Tor
  - Rac1
  - Rac2
  - Tpi
  - S6k
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Dif
  - dl
  - Rel
  - sgg
  - Axn
  - gskt
  - foxo
  - cass
  - p53
  - betaTub60D
  - hth
  - CycE
  - cyc
  - LPA
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PIK3CB
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - PIK3R5
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R6
  - MTOR
  - RAC1
  - RNASE1
  - SGK1
  - RPS6KB1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MDM2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - GSK3B
  - FOXO1
  - BAD
  - TP53
  - TP63
  - TP73
  - Hras
  - Kras
  - Rem1
  - Pik3ca
  - Ecm1
  - Ppp1r13b
  - Pik3cb
  - Pdpk1
  - Akt1
  - Pik3r5
  - Pik3r1
  - Sgk1
  - Rps6kb1
  - Mdm2
  - Nfkb1
  - Gsk3b
  - Foxo1
  - Bad
  - Trp53
  - rab1ab
  - ptenb
  - ddx3xb
  - pdk1
  - mtor
  - rac1a
  - sgk1
  - mdm2
  - gsk3ba
  - foxo3b
  - badb
  - tp53
  - Glucose
  - Cancer
  - Lung cancer
---
